Sight and Hearing Investigation Into Effects on Delirium — SHIELD  

Delirium Clinical Trial

Official title: Prospective Initiative to Examine and Address Hearing Loss, Vision Loss, and Delirium in a Hospital Setting

Status Active, not recruiting

Clinical Trial Summary

The goal of this observational study is to learn about sensory loss in hospital patients with delirium. The main questions it aims to answer are:

• Are hearing and vision loss related to increased risk of having delirium?

• Do hearing and vision loss contribute to more severe delirium?

• Do sensory loss and/or delirium affect patient satisfaction with hospital care?

Participants will be asked to:

• answer delirium screening questions,

• undergo hearing & vision screenings, and

• complete questionnaires about the hospital stay.

The second part of this study is a clinical trial. Researchers will compare different hospital units to see if changing communication affects the number of patients with delirium. The main questions it aims to answer are:

• Does sharing information about communication and/or providing hearing devices change the number of hospital patients with delirium?

Participants in the study will be asked to complete delirium screenings and answer questions about their hearing and communication.

Clinical Trial Description

This is a prospective cohort study entitled Sight & Hearing Investigation into Effects on Delirium (SHIELD), which aims of to characterize the impact of sensory impairment (i.e., vision and/or hearing loss) on inpatient delirium and experience. The initial phase of this research includes delirium, hearing, and vision screenings, as well as questionnaires regarding satisfaction with care, all of which are observational and do not constitute treatment or intervention. Researchers will conduct electronic medical record reviews to determine whether new patients have been admitted to the units of recruitment on a daily basis and collect relevant demographic and medical information. Eligible patients will be screened to with the 4AT identify delirium and the 3D-CAM-S to characterize delirium severity. After obtaining informed consent, patients will undergo bedside hearing and vision screenings, and complete patient satisfaction questionnaires.

The second phase of present study aims to determine the impact of improving communication on delirium in the hospital setting. Screenings will be used to identify delirium and measure severity and patients will be asked to report subjective hearing difficulty. Subsequent intervention will involve addressing communication barriers posed by hearing loss by providing training to clinical nursing staff, reinforcing strategies for effective communication through the use of posted signs, and providing amplification devices to eligible patients. ;

Related Conditions & MeSH terms

• Confusion
• Deafness
• Delirium
• Delirium Confusional State
• Delirium in Old Age
• Delirium of Mixed Origin
• Delirium on Emergence
• Delirium Superimposed on Dementia
• Delirium, Cause Unknown
• Dementia
• Emergence Delirium
• Hearing
• Hearing Disability
• Hearing Loss
• Hearing Loss, Age-Related
• Hearing Loss, Bilateral
• Hearing Loss, Functional
• Hearing Loss, High-Frequency
• Hearing Loss, Sensorineural
• Presbycusis

• NCT number: NCT06176625
• Study type: Interventional
• Source: Johns Hopkins University
• Status: Active, not recruiting
• Phase: N/A
• Start date: January 11, 2023
• Completion date: August 31, 2024